Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02591628 · ClinicalTrials.gov registry record · NA
Treatment of Hypertension In Adults With ThiaZIDES: Pragmatic Trial Pilot Study
A NA study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 2,027
- Enrollment target
NCT02591628: Completed NA study, sponsored by HealthPartners Institute.
NCT02591628 is a NA study that has completed, run by HealthPartners Institute. The registered enrollment target is 2,027 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02591628, a NA study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,027 participants
- Enrollment target
Study Summary
This proposed pilot study will test methods and feasibility for a large pragmatic clinical trial comparing two inexpensive, first-line drugs for treating high blood pressure to determine if one is superior in preventing serious cardiovascular events and death. It will develop and test novel approaches to conducting trials that will be faster, less expensive, and more realistic by being embedded in a typical practice setting and using advanced health information technology.
Primary Outcome
We will observe pharmacy claims to assess whether intervention patients filled their first prescription for chlorthalidone (primary adherence)
Interventions
- BEHAVIORAL HCTZ prescription conversion to chlorthalidone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,027 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-07 |
| Phase | NA |
What the finished NCT02591628 record still lists
NCT02591628 is an interventional study that assigns participants to a tested intervention. Its 2,027 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% higher).
The record links to 0 conditions, and to 1 intervention - of which HCTZ prescription conversion to chlorthalidone is the first listed.
NCT02591628 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02591628 about?
NCT02591628 is a clinical study titled "Treatment of Hypertension In Adults With ThiaZIDES: Pragmatic Trial Pilot Study". This proposed pilot study will test methods and feasibility for a large pragmatic clinical trial comparing two inexpensive, first-line drugs for treating high blood pressure to determine if one is superior in preventing serious cardiovascular events and death. It will develop and test novel approach...
What is the current status of trial NCT02591628?
This trial is currently completed. It is a NA study. The enrollment target is 2,027 participants. The study started on 2015-08. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02591628?
The interventions under investigation include: HCTZ prescription conversion to chlorthalidone (BEHAVIORAL).
Who is sponsoring clinical trial NCT02591628?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02591628's enrollment target sits among peer trials
2,027 52nd of 2000 higher than 1,949 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04216732 · 2,030 participants
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
- NCT05625659 · 2,032 participants · NA
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT06825897 · 2,039 participants · NA
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia